Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Please Try Again

Password Hint : {{passwordHint}}

Remember me

Liminal BioSciences Inc. LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc.

<< Previous

Bullboard Posts

Next >>

Post by Dibah420on May 08, 2021 8:34am

97 Views

Post# 33159320

$11

Liminal BioSciences Stock Forecast & Price Targets

Showing:

All Analyst Consensus & Price Target

Best Performing Analyst Consensus & Price TargetPremium

Analyst Rating Consensus

Moderate Buy

Based on 1 Analyst Ratings

1 Buy
0 Hold
0 Sell

Based on 1 Wall Street analysts offering stock ratings for Liminal BioSciences in the last 3 months (by analysts ranked 0 to 5 stars).

Analyst Price Target on LMNL

$11.00

(129.65% Upside)

Based on 1 analyst offering 12 month price targets for Liminal BioSciences in the last 3 months. The average price target is $11.00 with a high forecast of $11.00 and a low forecast of $11.00. The average price target represents a 129.65% increase from the last price of $4.79.